Phocas Financial Corp’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-273,788
Closed -$7.19M 212
2017
Q2
$7.19M Buy
273,788
+12,214
+5% +$300K 0.65% 68
2017
Q1
$6.12M Sell
261,574
-35,586
-12% -$878K 0.57% 72
2016
Q4
$7.47M Sell
297,160
-330
-0.1% -$8.33K 0.49% 81
2016
Q3
$8.35M Buy
297,490
+18,142
+6% +$465K 0.58% 63
2016
Q2
$6.89M Buy
279,348
+16,918
+6% +$420K 0.5% 81
2016
Q1
$5.8M Sell
262,430
-10,916
-4% -$291K 0.45% 100
2015
Q4
$9.57M Buy
273,346
+19,534
+8% +$612K 0.75% 34
2015
Q3
$7.23M Buy
253,812
+17,374
+7% +$584K 0.61% 63
2015
Q2
$7.87M Buy
236,438
+73,834
+45% +$2.27M 0.64% 50
2015
Q1
$4.58M Buy
+162,604
New +$4.04M 0.36% 133

Other funds holding PMC

Phocas Financial Corp's PMC Position: Q3 2017 in Review

Phocas Financial Corp sold out of PharMerica Corporation (PMC) in Q3 2017, closing a stake of 273,788 shares — an estimated $7.19M sold.

Phocas Financial Corp first reported a position in PMC in Q1 2015 and held it in 10 quarters. The position peaked at $9.57M in Q4 2015. 150 funds tracked by Wall St. Rank hold PMC as of Q3 2017.

  • Phocas Financial Corp reported no remaining PharMerica Corporation position as of Q3 2017 after selling out during the quarter.
  • Phocas Financial Corp sold 273,788 PharMerica Corporation shares in Q3 2017, an estimated $7.19M.
  • Phocas Financial Corp first reported a position in PharMerica Corporation in Q1 2015 and held it in 10 quarters.
  • Phocas Financial Corp's PharMerica Corporation position peaked at $9.57M in Q4 2015.
  • 150 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2017.

Based on Phocas Financial Corp's 13F filing for Q3 2017, filed 17 Nov 2017.